During the last meeting of the Board, it has been decided that the current Rare neurological diseases task force, founded in 2016, will be transformed into the first EAN Coordinating Panel.
The European Academy of Neurology is pleased to welcome Nepal as its new Corresponding Institutional Member!
From now on, the Nepal Academy of Neurology (NAN), led by President, Prof. Dr. Krishna Kumar Oli, is going to be invited as an observer to the EAN Assembly of Delegates and to an informal meeting with other Corresponding Institutional Members, taking place during the EAN congresses.
ESNR, the European Society of Neuroradiology, is with 5,000 members Europe’s leading radiological subspecialty society. Founded in 1969 we are celebrating our 50th birthday this year. A wide range of diagnostic and interventional neuroradiological topics including brain and spine imaging, head and neck imaging and pediatric neuroradiology are housed under the ESNR umbrella.
On behalf of the Ethics and Quality Task Force and based on the results of the participants evaluations, we announce the best speakers/presenters of educational courses at 5th EAN congress in Oslo, 29 June – 2 July 2019.
We congratulate… Continue Reading
On behalf of the Ethics and Quality Task Force and based on the results of the participants evaluations, we announce the best speakers/presenters of scientific courses at 5th EAN congress in Oslo, 29 June – 2 July 2019.
We congratulate… Continue Reading
Maria Stamelou, Co-Chair EQTF
Walter Struhal, Member EQTF
The Ethics and Quality Task Force (EQTF) was formed last year to replace the former Quality Assurance sub-Committee. This Task Force is an independent working group and reports directly to… Continue Reading
55th Turkish National Neurology Congress
15th – 21st November 2019, Antalya, Turkey
The Turkish Neurological Society aspires to make sure that the 55th edition of the national congress in 2019 is a more diverse, more active and more beneficial family… Continue Reading
With “involvement” as one of its five core values, EAN strives to encourage and strengthen the collaboration not only between the national societies and individual members but also among the related professional organisations, national and international, neurological associations and related… Continue Reading
The Scientific Committee is fully committed to a great mission: To increase and share the best clinical knowledge and the cutting-edge information from translational research in all neurological fields. Main actions are i) to facilitate exchanges and synergies with the Scientific Panels ii) to support the Guideline Production Group (update and diffusion of expertise and best clinical practice), iii) to interact positively with other scientific societies with reciprocal exchanges and liaise with the European Affairs sub-Committee to increase the awareness of Neurology in Europe.
In a recent article published in the August 2019 issue of the EAN Pages, we presented the framework based on which the collaboration between the EAN and the EFNR is currently unfolding. The Memorandum of Understanding between the two organizations, signed in 2017, is the guiding document that formally governs this partnership, which focuses on three key pillars for development: facilitating evidence-based clinical guideline production, promoting multidisciplinary education, and hosting joint sessions within the main scientific events organized annualy by these institutions. This article will focus on the latter priority for our collaboration, with the goal of disseminating relevant updates how our community benefits from the interaction between the EAN and the EFNR.
This month’s selected paper addresses the risk of neurological deficits in people with cavernomas treated with antithrombotic medication. Perhaps counter-intuitively, the authors report a lower risk of intracerebral haemorrhage in patients taking antithrombotic medication (mostly antiplatelet therapy). The study therefore provides reassurance for clinicians managing patients with this relatively common, and often incidental, vascular finding that antithrombotic therapy does not appear harmful; conversely, there could be some benefit, but this requires further evaluation in a randomised controlled trial.
Spain is the fourth-largest country in Europe, with a population of just more than 47 million, and is made up of mainland Spain, occupying the majority of the Iberian Peninsula, the Balearic islands in the Mediterranean, the cities of Ceuta and Melilla in North Africa, and the Canary Islands in the north-east Atlantic Ocean. Spain’s capital is Madrid, and the country is divided into 17 autonomous communities, which provide free, universal healthcare to all their inhabitants.